Ralf Lutterbüse
24Patents
8h-index
50Co-inventors
78Inventor score
Filing activity: Nov 16, 1998 → May 3, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7112324B1 | CD 19×CD3 specific polypeptides and uses thereof | Chemistry; Metallurgy | 130 | Expired |
| US7635472B2 | Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders | Chemistry; Metallurgy | 87 | Expired |
| US7575923B2 | CD19xCD3 specific polypeptides and uses thereof | Chemistry; Metallurgy | 48 | Expired |
| US8101722B2 | Less immunogenic binding molecules | Chemistry; Metallurgy | 35 | Active |
| US10294300B2 | Antibody constructs for DLL3 and CD3 | Chemistry; Metallurgy | 28 | Active |
| US8394926B2 | Pharmaceutical compositions with resistance to soluble CEA | Chemistry; Metallurgy | 18 | Active |
| US7435549B1 | Method of identifying binding site domains that retain the capacity of binding to an epitope | Chemistry; Metallurgy | 11 | Expired |
| US9765157B2 | Antibody constructs for CDH19 and CD3 | Chemistry; Metallurgy | 10 | Active |
| US10059766B2 | Antibody constructs for CDH19 and CD3 | Chemistry; Metallurgy | 7 | Active |
| US10683351B2 | Antibody constructs for DLL3 and CD3 | Chemistry; Metallurgy | 4 | Active |
| US10981998B2 | Cross-species-specific single domain bispecific single chain antibody | Chemistry; Metallurgy | 3 | Active |
| US11591396B2 | Antibody constructs for DLL3 and CD3 | Chemistry; Metallurgy | 3 | Active |
| US9695250B2 | Pharmaceutical compositions with resistance to soluble CEA | Chemistry; Metallurgy | 2 | Active |
| US9982063B2 | Pharmaceutical compositions with resistance to soluble CEA | Chemistry; Metallurgy | 2 | Active |
| US11472886B2 | Cross-species-specific PSMAxCD3 bispecific single chain antibody | Chemistry; Metallurgy | 2 | Active |
| US10851170B2 | Antibody constructs for CD70 and CD3 | Chemistry; Metallurgy | 2 | Active |
| US11661462B2 | Optimized cross-species specific bispecific single chain antibody contructs | Chemistry; Metallurgy | 1 | Active |
| US12304952B2 | Antibody constructs for DLL3 and CD3 | Chemistry; Metallurgy | 0 | Active |
| US11498964B2 | Antibody constructs for CDH19 and CD3 | Chemistry; Metallurgy | 0 | Active |
| US12297292B2 | Antibody constructs for CDH19 and CD3 | Chemistry; Metallurgy | 0 | Active |
| US11987633B2 | Cross-species-specific single domain bispecific single chain antibody | Chemistry; Metallurgy | 0 | Active |
| US11028171B2 | Bispecific antibody constructs for CDH3 and CD3 | Chemistry; Metallurgy | 0 | Active |
| US12281172B2 | Cross-species-specific PSMAxCD3 bispecific single chain antibody | Chemistry; Metallurgy | 0 | Active |
| US11926666B2 | Bispecific antibody constructs for CDH3 and CD3 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.